Dehydroemetine adverse effects: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) (Created page with "__NOTOC__ {{Dehydroemetine}} {{CMG}} <ref>{{Cite web | last = | first = | title = WHO Model Prescribing Information: Drugs Used in Parasitic Diseases - Second Edition: P...") |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Adverse Effects== | |||
====Local Reactions==== | |||
The injections are painful. Abscess formation is common. A local eczematous rash may follow inadvertent subcutaneous injection. Generalized urticarial and purpuric rashes are rare. | |||
====Neuromuscular Effects==== | |||
Weakness and muscular pain are common, particularly in the limbs and neck. Dyspnoea may also occur as a result of generalized weakness. These symptoms are dose-related and often precede evidence of cardiotoxicity. | |||
<ref>{{Cite web | last = | first = | title = WHO Model Prescribing Information: Drugs Used in Parasitic Diseases - Second Edition: Protozoa: Amoebiasis and giardiasis: Dehydroemetine | url = http://apps.who.int/medicinedocs/en/d/Jh2922e/2.1.3.html#Jh2922e.2.1.3 | publisher = | date = | accessdate = }}</ref> | ====Cardiac Effects==== | ||
[[Hypotension]], precordial pain, [[tachycardia]] and [[dysrhythmia]]s are the most frequent signs of cardiac impairment. Electrocardiographic changes, particularly flattening and inversion of the T wave and prolongation of the Q-T interval, provide an early indication of toxicity.<ref>{{Cite web | last = | first = | title = WHO Model Prescribing Information: Drugs Used in Parasitic Diseases - Second Edition: Protozoa: Amoebiasis and giardiasis: Dehydroemetine | url = http://apps.who.int/medicinedocs/en/d/Jh2922e/2.1.3.html#Jh2922e.2.1.3 | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Latest revision as of 00:38, 31 December 2013
| Dehydroemetine |
|---|
| MEBADIN® Prescribing Information |
| General Information |
| Clinical Information |
| Dosage and Administration |
| Precautions |
| Use in Pregnancy |
| Adverse Effects |
| Drug Interactions |
| Storage |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Adverse Effects
Local Reactions
The injections are painful. Abscess formation is common. A local eczematous rash may follow inadvertent subcutaneous injection. Generalized urticarial and purpuric rashes are rare.
Neuromuscular Effects
Weakness and muscular pain are common, particularly in the limbs and neck. Dyspnoea may also occur as a result of generalized weakness. These symptoms are dose-related and often precede evidence of cardiotoxicity.
Cardiac Effects
Hypotension, precordial pain, tachycardia and dysrhythmias are the most frequent signs of cardiac impairment. Electrocardiographic changes, particularly flattening and inversion of the T wave and prolongation of the Q-T interval, provide an early indication of toxicity.[1]